Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
BMJ Open Sport Exerc Med ; 10(1): e001559, 2024.
Article in English | MEDLINE | ID: mdl-38495958

ABSTRACT

Objectives: To investigate the network of stakeholders involved in rugby union research across the globe. Methods: Using author affiliations listed on scientific publications, we identified the organisations that contributed to rugby union research from 1977 to 2022 and examine collaboration through coauthorship indicators. We determined the locations and sectors of identified organisations and constructed a collaboration network. Network metrics, including degree centrality and betweenness centrality, are computed to identify influential organisations and measure intersector collaboration. Results: There is an increase in scientific knowledge creation and collaboration between organisations for rugby union research over time. Among the sectors, the university, professional sports team and sports governing body sectors exhibit the highest intersectoral and intrasectoral density. Predominantly, influential actors are located in England, Australia, France, New Zealand, Ireland and South Africa. Australian Catholic University, Leeds Beckett University, Stellenbosch University, Swansea University, University College London and the University of Cape Town emerge as influential actors between 2016 and 2022. Conclusions: Our study underscores the ongoing growth of scientific knowledge generation in rugby union, primarily led by organisations in tier 1 rugby-playing nations within the university sector. Intersectoral collaboration with sports governing bodies plays a crucial role, acting as a broker between sectors. However, the overall collaboration landscape between and within sectors is low. These results highlight an opportunity for improved collaboration opportunities, as the organisations driving knowledge creation have been identified.

2.
Front Pharmacol ; 14: 1317137, 2023.
Article in English | MEDLINE | ID: mdl-38235118

ABSTRACT

After nearly two decades of substantial investment in the field of nanomedicine within South Africa, this study undertakes an investigation into the specific diseases that have been targeted for research and development, as well as the key actors and collaborative networks involved in this burgeoning field. To accomplish this, the study adopts a mixed-method approach, combining bibliometric and scientometric techniques alongside a comprehensive review of existing literature. The study's findings illuminate that the diseases selected for emphasis in nanomedicine research closely align with the prevalent health challenges faced by South Africa. Notably, these ailments encompass cancer, bacterial infections, and tuberculosis, all of which significantly contribute to the country's disease burden. Furthermore, the investigation highlights that research-intensive South African universities play a pivotal role as the primary actors in advancing nanomedicine initiatives. Over time, collaborative endeavors among these key actors have seen a noteworthy upswing. These collaborations have fostered robust connections between South African institutions and counterparts in Asian nations and the Middle East. It is worth emphasizing that nanomedicine is a resource-intensive field, necessitating substantial capital investment. Collaborative initiatives have, in turn, granted access to critical infrastructure and materials that would have otherwise been beyond the reach of some participating entities. Remarkably, these collaborative partnerships have not only facilitated scientific progress but have also cultivated social capital and trust among involved stakeholders. These valuable intangible assets hold great potential as South Africa advances towards more exploitative phases of technology development within the domain of nanomedicine. Moreover, South Africa is strategically positioning itself to cultivate a critical mass of expertise in nanomedicine, recognising the significance of skilled human resources in harnessing the full potential of this technology in the future. Systematic Review Registration: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173875/.

3.
Health Res Policy Syst ; 15(1): 41, 2017 May 30.
Article in English | MEDLINE | ID: mdl-28558838

ABSTRACT

BACKGROUND: Explaining policy change is one of the central tasks of contemporary policy analysis. In this article, we examine the changes in infection control policies for multi-drug resistant tuberculosis (MDR-TB) in South Africa from the time the country made the transition to democracy in 1994, until 2015. We focus on MDR-TB infection control and refer to decentralised management as a form of infection control. Using Kingdon's theoretical framework of policy streams, we explore the temporal ordering of policy framework changes. We also consider the role of research in motivating policy changes. METHODS: Policy documents addressing MDR-TB in South Africa over the period 1994 to 2014 were extracted. Literature on MDR-TB infection control in South Africa was extracted from PubMed using key search terms. The documents were analysed to identify the changes that occurred and the factors driving them. RESULTS: During the period under study, five different policy frameworks were implemented. The policies were meant to address the overwhelming challenge of MDR-TB in South Africa, contextualised by high prevalence of HIV infection, that threatened to undermine public health programmes and the success of antiretroviral therapy rollouts. Policy changes in MDR-TB infection control were supported by research evidence and driven by the high incidence and complexity of the disease, increasing levels of dissatisfaction among patients, challenges of physical, human and financial resources in public hospitals, and the ideologies of the political leadership. Activists and people living with HIV played an important role in highlighting the importance of MDR-TB as well as exerting pressure on policymakers, while the mass media drew public attention to infection control as both a cause of and a solution to MDR-TB. CONCLUSION: The critical factors for policy change for infection control of MDR-TB in South Africa were rooted in the socioeconomic and political environment, were supported by extensive research, and can be framed using Kingdon's policy streams approach as an interplay of the problem of the disease, political forces that prevailed and alternative proposals.


Subject(s)
Health Policy , Infection Control/legislation & jurisprudence , Tuberculosis, Multidrug-Resistant/prevention & control , Antitubercular Agents/therapeutic use , HIV Infections/epidemiology , HIV Infections/prevention & control , Humans , Prevalence , South Africa , Tuberculosis, Multidrug-Resistant/epidemiology
4.
Syst Rev ; 5(1): 200, 2016 11 25.
Article in English | MEDLINE | ID: mdl-27884180

ABSTRACT

BACKGROUND: Mobile health (mHealth) has been described as a health enabling tool that impacts positively on the health system in terms of improved access, quality and cost of health care. The proposed systematic review will examine the impact of mHealth on health systems by assessing access, quality and cost of health care as indicators. METHODS: The systematic review will include literature from various sources including published and unpublished/grey literature. The databases to be searched include: PubMed, Cochrane Library, Google Scholar, NHS Health Technology Assessment Database and Web of Science. The reference lists of studies will be screened and conference proceedings searched for additional eligible reports. Literature to be included will have mHealth as the primary intervention. Two authors will independently screen the search output, select studies and extract data; discrepancies will be resolved by consensus and discussion with the assistance of the third author. DISCUSSION: The systematic review will inform policy makers, investors, health professionals, technologists and engineers about the impact of mHealth in strengthening the health system. In particular, it will focus on three metrics to determine whether mHealth strengthens the health system, namely quality of, access to and cost of health care services. Systematic review registration: PROSPERO CRD42015026070.


Subject(s)
Delivery of Health Care/economics , Health Services Accessibility , Quality of Health Care , Telemedicine/statistics & numerical data , Humans , Quality of Health Care/economics , Systematic Reviews as Topic , Telemedicine/economics
5.
Photochem Photobiol ; 89(4): 811-5, 2013.
Article in English | MEDLINE | ID: mdl-23437974

ABSTRACT

In upper-room ultraviolet germicidal irradiance (UVGI) design, irradiance is an important characteristic, with two opposing dominant dynamics: high-level irradiation on the microorganism and minimum levels of irradiance on human skin and eyes. The use of high-level ray-tracing procedures is followed in establishing radiance and irradiance levels. The main constants in a room influencing these calculations are the spectral and spatial characteristics of the radiation sources in the inter-reflecting surfaces inside the luminaire, as well as the surfaces in the room. The most important characteristic to be determined for the radiation source prior to calculations is its spatial radiant intensity distribution. This characterization is performed using a gonioradiometer. The complexity of the physical construction of the luminaire will determine the extent to which measurements have to be taken. Accurate gonioradiometer readings provide the required radiant intensities in all directions for computer-aided design (CAD), and can also be used to determine the total radiant flux leaving the luminaire, as well as calculating isoirradiance surfaces around the UVGI luminaire. This study will present a laboratory experimental approach to deriving the radiant intensity distribution of a UVGI luminaire. The UVGI luminaire is then characterized in situ, and compared with the gonioradiometric output.


Subject(s)
Air Microbiology , Disinfection/instrumentation , Disinfection/methods , Lighting/instrumentation , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...